Aled Williams

Chief Commercial Officer and Head of Patient Access



Aled Williams has more than twenty-five years of experience in healthcare and pharmaceuticals. Most recently, he served as Vice President and Global Strategy Head for rare gastrointestinal diseases at Shire where he was responsible for the commercialization and development of GATTEX® and Revestive® for short bowel syndrome. Additionally, he served as the Vice President and Global Strategy Head for Gaucher disease and the Global Commercial Team Leader for Hereditary Angioedema. Prior to Shire, he held leadership positions of increasing responsibility at Bristol-Myers Squibb, Novartis and Roche.

© All rights reserved, Sciencenews 2020